Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-17-049667

SVP & Chief Operating Officer sold 3,177 shares at $19.32 ($61,380)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Nicholson John SVP & Chief Operating Officer 2017-08-16 Sale −3,177 $19.32 $61,380 224,066 D: show line 1 in the form
Open-market sales · 3,177 sh · avg $19.32 · $61,380
Loading xslF345X03/doc4.xml…